Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced the granting of inducement awards to Rusty Page, VP Operations. In accordance with NASDAQ Listing Rule 5635(c)(4), the award was …
Neuronetics Reports Inducement Grant Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced it has been named a 2022 bronze winner by the Merit Awards for Healthcare in the HealthTech Patient Care category for its …
Neuronetics Announced as a Winner by 2022 Merit Awards for HealthCare in the Patient Care Category Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Senior Vice President, Chief Financial Officer, and Treasurer, will participate in …
Neuronetics to Present at the Piper Sandler 34th Annual Healthcare Conference Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) recently announced the latest advancements of the NeuroStar® Advanced Therapy system, which enhance both the software and console and continue to build on the …
Neuronetics Announces NeuroStar Advanced Therapy for Mental Health System Innovations Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced the recent granting of inducement awards to ten new non-executive employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved …
Neuronetics Reports Inducement Grant Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced its financial and operating results for the third quarter of 2022.
Neuronetics Reports Third Quarter 2022 Financial and Operating Results Read More MALVERN, PA —  Neuronetics, Inc. (NASDAQ: STIM) is named a 2022 bronze winner by the Merit Awards for Technology in the HealthTech category for its NeuroStar Advanced Therapy.
Neuronetics Announced as Winner by 2022 Merit Awards for Technology Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) recently announced healthcare policy updates that increase patient access to NeuroStar Advanced Therapy for Mental Health transcranial magnetic stimulation (TMS). The published and …
NeuroStar Advanced Therapy for Mental Health Now Covered for Nearly 8 Million Americans Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that it plans to release third quarter 2022 financial and operating results prior to market open on Tuesday, November 8th, 2022. The …
Neuronetics to Report Third Quarter 2022 Financial and Operating Results Read More MALVERN, PA —  Neuronetics, Inc. (NASDAQ: STIM) announced upgrades this week to the TrakStar® platform that will offer all NeuroStar® providers a more turnkey patient management experience.  Continuing Neuronetics’ commitment …
Neuronetics Releases Third TrakStar Upgrade in 2022 Read More